These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22082241)

  • 1. Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case-control study.
    Siegerink B; Meltzer ME; de Groot PG; Algra A; Lisman T; Rosendaal FR
    Br J Haematol; 2012 Jan; 156(2):252-8. PubMed ID: 22082241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men.
    Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
    Br J Haematol; 2009 Apr; 145(1):121-7. PubMed ID: 19170679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
    Urbanus RT; Siegerink B; Roest M; Rosendaal FR; de Groot PG; Algra A
    Lancet Neurol; 2009 Nov; 8(11):998-1005. PubMed ID: 19783216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofibrinolysis is a risk factor for arterial thrombosis at young age.
    Guimarães AH; de Bruijne EL; Lisman T; Dippel DW; Deckers JW; Poldermans D; Rijken DC; Leebeek FW
    Br J Haematol; 2009 Apr; 145(1):115-20. PubMed ID: 19183334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction.
    Leander K; Blombäck M; Wallén H; He S
    Thromb Haemost; 2012 Jun; 107(6):1092-9. PubMed ID: 22476576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and the risk of myocardial infarction.
    Tanis BC; van den Bosch MA; Kemmeren JM; Cats VM; Helmerhorst FM; Algra A; van der Graaf Y; Rosendaal FR
    N Engl J Med; 2001 Dec; 345(25):1787-93. PubMed ID: 11752354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis.
    Meltzer ME; Lisman T; Doggen CJ; de Groot PG; Rosendaal FR
    PLoS Med; 2008 May; 5(5):e97. PubMed ID: 18462012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of metabolic syndrome among young women with nonfatal myocardial infarction.
    Amowitz LL; Ridker PM; Rifai N; Loughrey CM; Komaroff AL
    J Womens Health (Larchmt); 2004 Mar; 13(2):165-75; discussion 175. PubMed ID: 15072730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) case-control study.
    Siegerink B; Govers-Riemslag JW; Rosendaal FR; Ten Cate H; Algra A
    Circulation; 2010 Nov; 122(18):1854-61. PubMed ID: 20956210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular outcomes after preeclampsia or eclampsia complicated by myocardial infarction or stroke.
    Gastrich MD; Gandhi SK; Pantazopoulos J; Zang EA; Cosgrove NM; Cabrera J; Sedjro JE; Bachmann G; Kostis JB;
    Obstet Gynecol; 2012 Oct; 120(4):823-31. PubMed ID: 22996100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study.
    Walldius G; Aastveit AH; Jungner I
    J Intern Med; 2006 Mar; 259(3):259-66. PubMed ID: 16476103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new global assay of coagulation and fibrinolysis.
    Goldenberg NA; Hathaway WE; Jacobson L; Manco-Johnson MJ
    Thromb Res; 2005; 116(4):345-56. PubMed ID: 16038720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
    Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
    Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction.
    Li YH; Chen JH; Tsai WC; Chao TH; Guo HR; Tsai LM; Wu HL; Shi GY
    Thromb Haemost; 2002 Jan; 87(1):86-91. PubMed ID: 11848462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
    Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in 24 hemostatic genes and associations with non-fatal myocardial infarction and ischemic stroke.
    Smith NL; Bis JC; Biagiotti S; Rice K; Lumley T; Kooperberg C; Wiggins KL; Heckbert SR; Psaty BM
    J Thromb Haemost; 2008 Jan; 6(1):45-53. PubMed ID: 17927806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.